BOLD vs CL · P/E 0.1, $24.6M cap vs P/E 34, rev $20.38B
Boundless Bio, Inc. Common Stock (BOLD) versus Colgate-Palmolive Company (CL) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Not investment advice. Open the BOLD and CL stock pages for the full models.
Not investment advice.